2011 / 040613 A8 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||. o B. ( 12 ) EEEEEEEE6LVUAEéhTﬂElIIEHjJE. . . . . EEEE <19>1ﬁg§§ggEEE * * r 2IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII ( 43> mm W0 ( 2%11Bﬁi : i ; i ) %6i?3 A8. 2011 E 4 E 7 EI ( 07.04.2011 ) . . . ( 51 ) EEEEE E=£ ' I - Ji"" : . A61K 31 / 713 ( 2006 01 ) A61P 35 / 04 ( 2006.01 ) A61K 31 / 7088 ( 2006.01 ) G01N 33 / 15 ( 2006.01 ) A61K 48 / 00 ( 2006.01 ) G01N 33 / 50 ( 2006.01 ) A61P 35 / 00 ( 2006.01 ) ( 21 ) IIEEIEEE : PCT / JP2010 / 067288 ( 22 ) IIIEEIEEI : 2010E10E 1 EI ( 01.10.2010 ) ( 25 ) IﬂEEIEE®EE EEE ( 26 ) IﬂEﬂFaﬁ®EE EIZISE. ( 30 ) EEE - F‘—5I : EEE 2009—230016 2009 E 10 E 1 EI ( 01.10.2009 ) JP. ( 71 ) EEA ( * EEIE < ET®$EEEEI : OLVC ) : E LL1TEI 3fAlLLfJ‘AJE3¥g°L‘E J9— ( Nati0nal Cancer Center ) [ JP / JP ] ; T 1040045 E E E EI : E II EE £TE 1 E 1 E T6ky6 ( JP ) EEEEEEEE I z : E ( Dainipp0n Sumit0m0 Pharma C0. , Ltd. ) [ JP / JP ] ; T5418524 EEEEEEEEEEEE 2 T E 6 E 8 E Osaka ( JP ) . EEHE‘ ; EBotU EaHE / mIEA ( ElI : oLrC0 ) J + ) : EE E0 : ( 0CH1YA , Takahir0 ) [ JP / JP ] ; ?1040045 EEEEE EEEEETE1E1E ﬁﬁﬁﬁ EAEL ' U> AIEE - t / 5I— W Tokyo ( J_P ) EE ( TAKAHAsH1 , Ry0u - u ) [ JP / JP ] ; T 1040045 EE EEEEEfLTE 1 E 1 E ﬁﬁﬁﬁ EAE L"L1b\‘A / I53¥E - Iz / 5I— —I7<J T0ky0 ( JP ) . ( 74 ) m E A : E E — ( TAKAsHIMA , Hajime ) ; F 5410044 XIﬁHEXBJiFﬁEFEIZIﬁEEITlTE 1 E EEE EEEEEEE I : “ ) b Osaka ( JP ) . ( 72 ) ( 75 ) . 1E EEE. ( 81 ) EE‘I ( E7T=0 ) 1QEL\BE U . E ' CCDEECDI WE E 75‘EIﬁE ) : AE , AG , AL , AM , A0 , AT , AU , Az , BA , BB , BG , BH , BR , BW , BY , BZ , CA , CH , CL , CN , C0 , CR , CU , CZ , DE , DK , DM , D0 , DZ , EC , EE , EG , Es , FI , GB , GD , GE , GH , GM , GT , HN , HR , HU , ID , IL , IN , 1s , JP , KE , KG , KM , KN , KP , KR , KZ , LA , LC , LK , LR , Ls , LT , LU , LY , MA , MD , ME , MG , MK , MN , MW , MX , MY , MZ , NA , NG , N1 , N0 , NZ , 0M , PE , PG , PH , PL , PT , R0 , Rs , RU , sC , sD , SE , sG , sK , sL , sM , sT , SV , sY , TH , TJ , TM , TN , TR , TT , TZ , UA , UG , Us , UZ , VC , VN , zA , ZM , ZW. EEl ( En - =01 ; ME U . E - cmEEmEEIE E 75“ E E ) : AR1P0 ( BW , GH , GM , KE , LR , Ls , MW , MZ , NA , sD , sL , sz , TZ , UG , ZM , zW ) . : L — 5 9 7 ( AM , AZ , BY , KG , KZ , MD , RU , TJ , TM ) , EI — III v / \° ( AL , AT , BE , BG , CH , CY , CZ , DE , DK , EE , ES , FI , FR , GB , GR , HR , HU , IE , IS , IT , LT , LU , LV , MC , MK , MT , NL , N0 , PL , PT , R0 , Rs , SE , s1 , sK , sM , TR ) , 0AP1 ( BF , BJ , CF , CG , C1 , CM , GA , GN , GQ , GW , ML , MR , NE , sN , TD , TG ) . EEEEEE — EEEEEEE ( ( E11~JE21E ( 3 ) ) . — EEEEE®ﬁ|IIIEIcDE ﬁt LTELfﬂMU U R I - ( EEU 5. 2 ( a ) ) . ( 48 ) C ®§TIEHJTZ0M§EEEJ E : . ( 15 ) ETIE ' IEE : 2011 E 7 E 14 EI ®EEﬁ ' IE$ﬁ ( N0tice ) EEE. ( 84 ) . 2011E7E14EI. . ( 54 ) Title : THBRAPBUT1C AGFNT F0R TUM0R ( 54 ) EEﬂ®E E : EEEEE. ( 57 ) Abstract : Disc10sed are a therapeutic agent f0r tum0r , in particu1ar , drug - resistant cancer , an agent f0r inhibiting 0r preVenting tum0r metastasis , and an agent f0r inhibiting 0r preVenting cancer recurrence , each c0mprising n1iR27b 0r a nuc1eic acid c0n - taining a nuc1e0tide Which c0mprises a nuc1e0tide sequence haVing a 70% 0r m0re identity With the nuc1e0tide sequence represented by SEQ ID NO : 1 and has the same functi0n as that 0f miR27b. N ( 57 ) EE. EEEEE miR27b Ef : I2I : EE§|JEE1 EE$mé3Z7 b7J ' 7 - FEMIIJ : 70%l ; lJ : CD|E. — ' I$E7Eﬁ‘. é3Z ) Izﬁ ' ? FEE7§|J1J\B7‘J : U ﬂO miR27b tEE®EﬁEEE¢éR7 I / 7J ' 7 - PEELEiEEEEﬁX EEE iEI : Eﬁ|Jﬂﬁ¢ ' I$75iA / ®3EE§|J‘ EEE®$1E$§EiIﬂE|JEf : IQ : EBHEéﬁ|L biAJEEEimElJEfdiEﬂHjVéﬁIJE. iEIEEéo